CRUK Oxford Centre
  • Home
  • About
    • Vision & Strategy
    • Governance
    • Membership
    • The Oxford Team
  • Research & Researchers
    • Oxford’s Cancer Researchers
    • Research Showcase
      • Cancer Big Data
      • Early Detection
      • Engineering Better Outcomes
      • Digestive Tract Cancer
      • Immunity, Infection and Inflammation
      • Blood Cancers
    • Networks & Consortia
      • Oxford Lymphoid Disorders Study Group
      • Advanced Radiotherapy Technologies Network
      • Cellular-Molecular Pathology
      • PathLAKE
      • S:CORT
      • ACRCelerate
      • EHNBPCCG
      • EPIC
      • Southampton Immune Accelerator
      • Marseille-Oxford Collaboration
      • NCIMI
      • Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre
      • PancrImmune
    • Clinical Studies
      • NuTide 301
      • TARDOX
  • Centre Support
    • Funding Opportunities
      • Development Fund
        • Previous Awards
      • CRUK Funding Calls
      • Other Funding Calls
    • Clinical Positioning Services
    • Translational Histopathology Laboratory
      • Multi-plex Immunofluorescence (IF) Imaging
      • RNAscope®
      • TMA Construction
      • Slide Scanning, Automated Tissue Segmentation and Scoring
      • Single and Double Antibody Tissue Staining (Chromogenic IHC)
      • Antibody Optimisation
      • Hematoxylin & Eosin (H&E) Staining
      • Tissue Processing, Embedding and Sectioning
    • Oxford Molecular Diagnostics Centre
    • Patient & Public Involvement in Research
    • Public Engagement
    • Informatics Tools
    • Sample Collection
    • Clinical Trial Support
    • Branding Toolkit
  • Oxford Cancer Academy
    • DPhil in Cancer Science Programme
      • Non-clinician DPhil Studentships
      • Clinical DPhil Studentships & Fellowships
      • Alumni destinations
  • News
  • Events
    • Annual Symposium
  • Contact
    • Contact us
    • Locate the Centre
  • Search

Oxford’s clinical researchers announce new 7 year collaboration with Janssen

August 5, 2019/in Front page, Uncategorized /by Oxford Centre
Read more →
http://www.cancercentre.ox.ac.uk/wp-content/uploads/2018/08/blood-e1534763800340.jpg 270 274 Oxford Centre http://www.cancercentre.ox.ac.uk/wp-content/uploads/2014/09/ocrc-cruk-logo-new-600x132.png Oxford Centre2019-08-05 15:17:242019-08-05 15:17:24Oxford’s clinical researchers announce new 7 year collaboration with Janssen

Recent Posts

  • Bowel cancer patients going undiagnosed due to COVID distruption
  • “The Oxford Classic” classification system uncovers new information about ovarian cancers
  • Oxford spin out financed $6.8m for research into oncolytic therapies
  • Being a part of cancer drug discoveries
  • Investigating the effects of co-morbidities on liver cancer risk

Archives

Quick Links

  • Home
  • About
  • Research
  • Funding
  • Graduate studies
  • Events
  • Engagement
  • Sitemap
  • Privacy
  • Terms
  • Cookies
  • Branding Toolkit

    • LATEST NEWS

    • Bowel cancer patients going undiagnosed due to COVID distruptionJanuary 15, 2021 - 10:47 am
    • Prof Ahmed Ahmed in his lab“The Oxford Classic” classification system uncovers new information about ovarian cancersJanuary 14, 2021 - 8:05 am
    • Oxford spin out financed $6.8m for research into oncolytic therapiesJanuary 7, 2021 - 5:13 pm

    CONTACT

    You can keep in touch in a number of ways:

    • Visit the contact page
    • Tel: 01865 617043
    • cancercentre@oncology.ox.ac.uk
    • View the locate Centre page
    Followon TwitterSubscribeto RSS Feed

    OUR PARTNERS

    Cancer Research UK

    University Of Oxford

    Oxford University Hospitals NHS Trust

    © Copyright 2016 - CRUK Oxford Centre - Web design by Arnie
    Scroll to top